This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated bullish coverage on VRT, VYLR, ATHR, LMRI and NVT, assigning Buy or Outperform ratings and price targets.
Stocks · News reference
Lumexa Imaging Holdings Q2 Adj. EPS $0.20 Beats $0.16 Estimate, Sales $264.200M Beat $263.113M Estimate
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.16 by 25 percent. The company reported quarterly sales of $264.200 million which beat
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18
Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.
Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18
Keybanc analyst Matthew Gillmor initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $18.
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $9 to $13.